The End for ICN's Milan Panic?

After four decades heading the drug company he founded, a new board appears certain to bring the tycoon's sometimes stormy reign to a close

Milan Panic's 42 years at the helm of ICN Pharmaceuticals may be nearing an end. At the company's annual meeting on May 29, ICN shareholders appear to have approved the election of three dissident directors who are expected to seek Panic's removal as chairman and chief executive of the Costa Mesa (Calif.)-based, company that he founded in 1960.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.